Baydas Burhanettin, Karagoz Suzan, Meral Ismail
Department of Physiology, Veterinary Medicine, Yuzuncu Yil University, Van, Turkey.
Biol Trace Elem Res. 2002 Sep;88(3):247-53. doi: 10.1385/BTER:88:3:247.
This study was designed to investigate the effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in alloxan-induced diabetic rats. Thirty-two albino male rats, weighing 234 +/- 34 g, were divided into four experimental groups (control, diabetic, diabetic+zinc supplemented and diabetic+ magnesium supplemented). The experiment lasted for 60 d. The first 45 d of the experiment was the supplementation and last 15 d was the supplementation and diabetes-inducing period. Diabetic+zinc-supplemented and diabetic+magnesium-supplemented groups were given orally (by adding in their drinking water) 227 mg/L of zinc and 100 mg/kg body weight (bw) of magnesium, respectively throughout the experiment. Control and diabetic groups served as controls and did not receive zinc or magnesium supplementation. Diabetic, diabetic+zinc-supplemented, and diabetic+magnesium-supplemented groups were given a daily injection (ip) of 100 mg/kg bw of alloxan for 15 d starting on d 46 of the experiment. The control group was only injected with the same volume of isotonic NaCl as the diabetic group received. At the end of the of the experiment, rats in all four groups were fasted for 12 h and blood samples were taken from the heart under ether anesthesia for the determination of thyroid hormone, glucose, total cholesterol, and triglyceride concentrations. It was found that serum glucose, total cholesterol, and triglyceride concentrations were higher and serum T3 and T4 concentrations were lower in diabetic rats than those in the control group. Zinc supplementation did not change any parameter in diabetic rats. However, magnesium supplementation decreased the elevated total cholesterol and triglyceride concentrations of the diabetic rats to the control level. It was concluded that oral magnesium supplementation might decrease the diabetes-induced disturbances of lipid metabolism.
本研究旨在探讨口服补充锌和镁对四氧嘧啶诱导的糖尿病大鼠血清甲状腺激素和血脂水平的影响。将32只体重为234±34 g的白化雄性大鼠分为四个实验组(对照组、糖尿病组、糖尿病+补锌组和糖尿病+补镁组)。实验持续60天。实验的前45天为补充期,最后15天为补充和诱导糖尿病期。在整个实验过程中,糖尿病+补锌组和糖尿病+补镁组分别通过饮水口服227 mg/L的锌和100 mg/kg体重的镁。对照组和糖尿病组作为对照,未接受锌或镁补充。从实验第46天开始,糖尿病组、糖尿病+补锌组和糖尿病+补镁组每天腹腔注射100 mg/kg体重的四氧嘧啶,持续15天。对照组仅注射与糖尿病组相同体积的等渗氯化钠。实验结束时,所有四组大鼠禁食12小时,在乙醚麻醉下从心脏采集血样,用于测定甲状腺激素、葡萄糖、总胆固醇和甘油三酯浓度。结果发现,糖尿病大鼠的血清葡萄糖、总胆固醇和甘油三酯浓度较高,血清T3和T4浓度低于对照组。补锌对糖尿病大鼠的任何参数均无影响。然而,补镁可将糖尿病大鼠升高的总胆固醇和甘油三酯浓度降至对照水平。得出的结论是,口服补镁可能会减轻糖尿病引起的脂质代谢紊乱。